| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 7.90e-07 | 739 | 16 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.07e-06 | 1160 | 16 | 8 | GO:0030674 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.96e-06 | 303 | 16 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 3.48e-06 | 1356 | 16 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.86e-05 | 562 | 16 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.92e-05 | 582 | 16 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.32e-04 | 753 | 16 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.80e-04 | 417 | 16 | 4 | GO:0061629 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 5.09e-04 | 42 | 16 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.07e-03 | 61 | 16 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.37e-03 | 875 | 16 | 4 | GO:0019904 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.73e-03 | 167 | 16 | 2 | GO:0031490 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 9.60e-03 | 187 | 16 | 2 | GO:0016922 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.41e-02 | 229 | 16 | 2 | GO:0140993 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.34e-06 | 266 | 16 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 2.01e-06 | 540 | 16 | 6 | GO:1903706 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 3.29e-06 | 1390 | 16 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 6.20e-06 | 162 | 16 | 4 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.37e-05 | 429 | 16 | 5 | GO:1902105 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 1.99e-05 | 1242 | 16 | 7 | GO:0002684 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 2.77e-05 | 237 | 16 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 3.01e-05 | 242 | 16 | 4 | GO:1902107 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.01e-05 | 242 | 16 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 3.01e-05 | 242 | 16 | 4 | GO:1903708 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 4.04e-05 | 537 | 16 | 5 | GO:0030098 | |
| GeneOntologyBiologicalProcess | head development | 4.19e-05 | 919 | 16 | 6 | GO:0060322 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 4.65e-05 | 553 | 16 | 5 | GO:0002757 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 5.08e-05 | 95 | 16 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated glucocorticoid signaling pathway | 7.62e-05 | 17 | 16 | 2 | GO:0042921 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 7.65e-05 | 614 | 16 | 5 | GO:0051249 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 7.71e-05 | 615 | 16 | 5 | GO:0002764 | |
| GeneOntologyBiologicalProcess | activation of immune response | 8.19e-05 | 623 | 16 | 5 | GO:0002253 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated corticosteroid signaling pathway | 8.57e-05 | 18 | 16 | 2 | GO:0031958 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 9.31e-05 | 640 | 16 | 5 | GO:1903131 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.04e-04 | 333 | 16 | 4 | GO:0051054 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 1.12e-04 | 1095 | 16 | 6 | GO:0060284 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 1.36e-04 | 694 | 16 | 5 | GO:0002694 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 1.39e-04 | 359 | 16 | 4 | GO:0002429 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell proliferation | 1.41e-04 | 23 | 16 | 2 | GO:0030889 | |
| GeneOntologyBiologicalProcess | P-body assembly | 1.41e-04 | 23 | 16 | 2 | GO:0033962 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.71e-04 | 143 | 16 | 3 | GO:0045739 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.77e-04 | 382 | 16 | 4 | GO:0030217 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.82e-04 | 146 | 16 | 3 | GO:2000779 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.82e-04 | 385 | 16 | 4 | GO:0051251 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | 1.97e-04 | 393 | 16 | 4 | GO:0002768 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | 2.04e-04 | 756 | 16 | 5 | GO:0050865 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 2.05e-04 | 1223 | 16 | 6 | GO:0030097 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 2.48e-04 | 789 | 16 | 5 | GO:0002521 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 2.61e-04 | 423 | 16 | 4 | GO:0002696 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 3.28e-04 | 449 | 16 | 4 | GO:0050867 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 3.42e-04 | 845 | 16 | 5 | GO:0050778 | |
| GeneOntologyBiologicalProcess | cell activation | 3.60e-04 | 1356 | 16 | 6 | GO:0001775 | |
| GeneOntologyBiologicalProcess | brain development | 3.68e-04 | 859 | 16 | 5 | GO:0007420 | |
| GeneOntologyBiologicalProcess | positive regulation of erythrocyte differentiation | 3.70e-04 | 37 | 16 | 2 | GO:0045648 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 4.01e-04 | 875 | 16 | 5 | GO:0045596 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 4.06e-04 | 475 | 16 | 4 | GO:0140694 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell activation | 4.77e-04 | 42 | 16 | 2 | GO:0050869 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 5.51e-04 | 213 | 16 | 3 | GO:2000045 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 5.84e-04 | 1483 | 16 | 6 | GO:0048646 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 6.54e-04 | 226 | 16 | 3 | GO:0045580 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | 6.62e-04 | 976 | 16 | 5 | GO:0046649 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 7.04e-04 | 51 | 16 | 2 | GO:1902459 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 7.24e-04 | 234 | 16 | 3 | GO:0006282 | |
| GeneOntologyBiologicalProcess | spleen development | 7.31e-04 | 52 | 16 | 2 | GO:0048536 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 7.75e-04 | 564 | 16 | 4 | GO:0051052 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 8.37e-04 | 246 | 16 | 3 | GO:1902806 | |
| GeneOntologyBiologicalProcess | protein destabilization | 8.48e-04 | 56 | 16 | 2 | GO:0031648 | |
| GeneOntologyBiologicalProcess | regulation of erythrocyte differentiation | 9.73e-04 | 60 | 16 | 2 | GO:0045646 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.06e-03 | 614 | 16 | 4 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of immune response | 1.07e-03 | 1085 | 16 | 5 | GO:0050776 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 1.11e-03 | 271 | 16 | 3 | GO:0000082 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.14e-03 | 65 | 16 | 2 | GO:0000288 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.32e-03 | 288 | 16 | 3 | GO:0045637 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.34e-03 | 1141 | 16 | 5 | GO:0045597 | |
| GeneOntologyBiologicalProcess | positive regulation of non-canonical NF-kappaB signal transduction | 1.40e-03 | 72 | 16 | 2 | GO:1901224 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 1.47e-03 | 74 | 16 | 2 | GO:0042733 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 1.57e-03 | 306 | 16 | 3 | GO:0044843 | |
| GeneOntologyBiologicalProcess | leukocyte activation | 1.60e-03 | 1186 | 16 | 5 | GO:0045321 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.64e-03 | 78 | 16 | 2 | GO:2000036 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.66e-03 | 1197 | 16 | 5 | GO:0007417 | |
| GeneOntologyBiologicalProcess | regulation of B cell proliferation | 1.72e-03 | 80 | 16 | 2 | GO:0030888 | |
| GeneOntologyBiologicalProcess | T cell activation | 1.74e-03 | 701 | 16 | 4 | GO:0042110 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.81e-03 | 1220 | 16 | 5 | GO:0051093 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.85e-03 | 324 | 16 | 3 | GO:0006302 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 1.90e-03 | 84 | 16 | 2 | GO:0061180 | |
| GeneOntologyBiologicalProcess | sensory organ development | 2.02e-03 | 730 | 16 | 4 | GO:0007423 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.13e-03 | 741 | 16 | 4 | GO:0006338 | |
| GeneOntologyBiologicalProcess | B cell activation | 2.14e-03 | 341 | 16 | 3 | GO:0042113 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 2.17e-03 | 90 | 16 | 2 | GO:0098586 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.17e-03 | 343 | 16 | 3 | GO:0090596 | |
| GeneOntologyBiologicalProcess | heart development | 2.30e-03 | 757 | 16 | 4 | GO:0007507 | |
| GeneOntologyBiologicalProcess | rhythmic process | 2.49e-03 | 360 | 16 | 3 | GO:0048511 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 2.83e-03 | 103 | 16 | 2 | GO:0002088 | |
| GeneOntologyBiologicalProcess | regulation of smoothened signaling pathway | 2.94e-03 | 105 | 16 | 2 | GO:0008589 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.77e-06 | 1377 | 16 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | transcription regulator complex | 3.29e-06 | 596 | 16 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 4.26e-05 | 13 | 16 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.51e-05 | 272 | 16 | 4 | GO:0090575 | |
| GeneOntologyCellularComponent | npBAF complex | 4.97e-05 | 14 | 16 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.36e-04 | 30 | 16 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | chromatin | 5.38e-04 | 1480 | 16 | 6 | GO:0000785 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.40e-03 | 96 | 16 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | P-body | 2.71e-03 | 102 | 16 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | ATPase complex | 4.28e-03 | 129 | 16 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 6.28e-03 | 157 | 16 | 2 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 7.32e-03 | 170 | 16 | 2 | GO:1902911 | |
| MousePheno | abnormal neural tube closure | 2.39e-06 | 378 | 16 | 6 | MP:0003720 | |
| MousePheno | abnormal hematopoietic precursor cell morphology | 1.56e-05 | 299 | 16 | 5 | MP:0013707 | |
| MousePheno | abnormal bone marrow cell number | 2.33e-05 | 154 | 16 | 4 | MP:0000172 | |
| MousePheno | decreased myeloid cell number | 2.45e-05 | 567 | 16 | 6 | MP:0013662 | |
| MousePheno | ileum inflammation | 2.57e-05 | 7 | 16 | 2 | MP:0009482 | |
| MousePheno | increased lymphoma incidence | 2.98e-05 | 164 | 16 | 4 | MP:0012431 | |
| MousePheno | abnormal neural tube morphology | 3.10e-05 | 591 | 16 | 6 | MP:0002151 | |
| MousePheno | impaired hematopoiesis | 3.11e-05 | 55 | 16 | 3 | MP:0001606 | |
| MousePheno | absent pre-B cells | 4.40e-05 | 9 | 16 | 2 | MP:0000238 | |
| MousePheno | increased hemolymphoid system tumor incidence | 5.40e-05 | 191 | 16 | 4 | MP:0010296 | |
| MousePheno | abnormal blood cell morphology/development | 5.53e-05 | 986 | 16 | 7 | MP:0002429 | |
| MousePheno | decreased pre-B cell number | 5.64e-05 | 67 | 16 | 3 | MP:0008209 | |
| MousePheno | hemorrhage | 5.97e-05 | 664 | 16 | 6 | MP:0001914 | |
| MousePheno | cecum inflammation | 9.51e-05 | 13 | 16 | 2 | MP:0009481 | |
| MousePheno | abnormal visceral yolk sac morphology | 1.23e-04 | 236 | 16 | 4 | MP:0001718 | |
| MousePheno | abnormal chorionic plate morphology | 1.28e-04 | 15 | 16 | 2 | MP:0004560 | |
| MousePheno | pallor | 1.29e-04 | 239 | 16 | 4 | MP:0003717 | |
| MousePheno | abnormal lung morphology | 1.33e-04 | 767 | 16 | 6 | MP:0001175 | |
| MousePheno | abnormal pre-B cell morphology | 1.65e-04 | 96 | 16 | 3 | MP:0002403 | |
| MousePheno | abnormal pulmonary alveolus morphology | 1.66e-04 | 255 | 16 | 4 | MP:0002270 | |
| MousePheno | abnormal myeloid cell number | 1.75e-04 | 806 | 16 | 6 | MP:0013661 | |
| MousePheno | abnormal definitive hematopoiesis | 1.78e-04 | 808 | 16 | 6 | MP:0002123 | |
| MousePheno | small intestinal inflammation | 1.86e-04 | 18 | 16 | 2 | MP:0003306 | |
| MousePheno | thrombocytopenia | 2.15e-04 | 273 | 16 | 4 | MP:0003179 | |
| MousePheno | abnormal hemopoiesis | 2.18e-04 | 839 | 16 | 6 | MP:0013693 | |
| MousePheno | abnormal blood circulation | 2.27e-04 | 845 | 16 | 6 | MP:0002128 | |
| MousePheno | pale yolk sac | 2.46e-04 | 110 | 16 | 3 | MP:0001722 | |
| MousePheno | abnormal pulmonary acinus morphology | 2.50e-04 | 284 | 16 | 4 | MP:0010911 | |
| MousePheno | abnormal nervous system development | 2.58e-04 | 1257 | 16 | 7 | MP:0003861 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 2.60e-04 | 112 | 16 | 3 | MP:0004808 | |
| MousePheno | abnormal smooth muscle morphology | 2.67e-04 | 113 | 16 | 3 | MP:0000767 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 2.93e-04 | 296 | 16 | 4 | MP:0010899 | |
| MousePheno | abnormal extraembryonic tissue morphology | 3.36e-04 | 908 | 16 | 6 | MP:0002086 | |
| MousePheno | decreased thymocyte number | 3.76e-04 | 127 | 16 | 3 | MP:0000715 | |
| MousePheno | abnormal lung development | 5.22e-04 | 142 | 16 | 3 | MP:0001176 | |
| MousePheno | embryonic growth arrest | 5.30e-04 | 346 | 16 | 4 | MP:0001730 | |
| MousePheno | abnormal vascular branching morphogenesis | 6.35e-04 | 33 | 16 | 2 | MP:0003227 | |
| MousePheno | abnormal respiratory system morphology | 6.53e-04 | 1027 | 16 | 6 | MP:0002132 | |
| MousePheno | increased central memory CD8 positive, alpha-beta T cell number | 7.15e-04 | 35 | 16 | 2 | MP:0010847 | |
| MousePheno | abnormal respiratory system development | 7.39e-04 | 160 | 16 | 3 | MP:0003115 | |
| MousePheno | increased classified tumor incidence | 7.62e-04 | 381 | 16 | 4 | MP:0010273 | |
| MousePheno | abnormal intestinal mucosa morphology | 7.66e-04 | 162 | 16 | 3 | MP:0000511 | |
| MousePheno | digestive/alimentary phenotype | 7.70e-04 | 1500 | 16 | 7 | MP:0005381 | |
| MousePheno | abnormal classified tumor incidence | 7.85e-04 | 384 | 16 | 4 | MP:0020188 | |
| MousePheno | abnormal CD8-positive, alpha-beta T cell differentiation | 7.99e-04 | 37 | 16 | 2 | MP:0008080 | |
| MousePheno | abnormal gland physiology | 8.05e-04 | 691 | 16 | 5 | MP:0002164 | |
| MousePheno | salivary gland inflammation | 8.43e-04 | 38 | 16 | 2 | MP:0001870 | |
| MousePheno | abnormal IgG level | 8.48e-04 | 392 | 16 | 4 | MP:0020174 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 8.54e-04 | 700 | 16 | 5 | MP:0011098 | |
| MousePheno | decreased B cell number | 8.64e-04 | 394 | 16 | 4 | MP:0005017 | |
| MousePheno | increased organ/body region tumor incidence | 8.72e-04 | 395 | 16 | 4 | MP:0010274 | |
| MousePheno | short maxilla | 8.88e-04 | 39 | 16 | 2 | MP:0000097 | |
| MousePheno | abnormal platelet cell number | 8.89e-04 | 397 | 16 | 4 | MP:0011898 | |
| MousePheno | abnormal organ/body region tumor incidence | 9.23e-04 | 401 | 16 | 4 | MP:0013152 | |
| MousePheno | increased effector memory CD4-positive, alpha-beta T cell number | 9.81e-04 | 41 | 16 | 2 | MP:0010844 | |
| MousePheno | abnormal embryonic tissue morphology | 1.02e-03 | 1116 | 16 | 6 | MP:0002085 | |
| MousePheno | abnormal central memory CD8-positive, alpha-beta T cell number | 1.03e-03 | 42 | 16 | 2 | MP:0012772 | |
| MousePheno | abnormal central memory CD8 positive, alpha-beta T cell morphology | 1.03e-03 | 42 | 16 | 2 | MP:0010846 | |
| MousePheno | decreased cell proliferation | 1.09e-03 | 739 | 16 | 5 | MP:0000352 | |
| MousePheno | abnormal lymph node B cell domain morphology | 1.13e-03 | 44 | 16 | 2 | MP:0002344 | |
| MousePheno | abnormal small intestine morphology | 1.16e-03 | 187 | 16 | 3 | MP:0000496 | |
| MousePheno | small lens | 1.23e-03 | 46 | 16 | 2 | MP:0001306 | |
| MousePheno | decreased common myeloid progenitor cell number | 1.29e-03 | 47 | 16 | 2 | MP:0008813 | |
| MousePheno | increased bone marrow cell number | 1.29e-03 | 47 | 16 | 2 | MP:0000321 | |
| MousePheno | intestinal inflammation | 1.31e-03 | 195 | 16 | 3 | MP:0001858 | |
| MousePheno | abnormal exocrine gland physiology | 1.33e-03 | 196 | 16 | 3 | MP:0013559 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell number | 1.34e-03 | 48 | 16 | 2 | MP:0012770 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell morphology | 1.34e-03 | 48 | 16 | 2 | MP:0010843 | |
| MousePheno | abnormal lymph node cortex morphology | 1.46e-03 | 50 | 16 | 2 | MP:0002343 | |
| MousePheno | increased cellular sensitivity to gamma-irradiation | 1.58e-03 | 52 | 16 | 2 | MP:0002007 | |
| MousePheno | decreased CD8-positive, naive alpha-beta T cell number | 1.58e-03 | 52 | 16 | 2 | MP:0013435 | |
| MousePheno | increased T cell derived lymphoma incidence | 1.64e-03 | 53 | 16 | 2 | MP:0002024 | |
| MousePheno | increased thymus tumor incidence | 1.70e-03 | 54 | 16 | 2 | MP:0010365 | |
| MousePheno | abnormal skin appearance | 1.70e-03 | 473 | 16 | 4 | MP:0009931 | |
| MousePheno | abnormal digestive system morphology | 1.72e-03 | 1233 | 16 | 6 | MP:0000462 | |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 1.76e-03 | 55 | 16 | 2 | MP:0010834 | |
| MousePheno | abnormal intercellular signaling peptide or protein level | 1.80e-03 | 480 | 16 | 4 | MP:0008835 | |
| MousePheno | abnormal tooth number | 1.82e-03 | 56 | 16 | 2 | MP:0030611 | |
| MousePheno | decreased hematopoietic stem cell number | 1.89e-03 | 57 | 16 | 2 | MP:0004810 | |
| MousePheno | limbs/digits/tail phenotype | 1.90e-03 | 1258 | 16 | 6 | MP:0005371 | |
| MousePheno | abnormal IgM level | 1.92e-03 | 223 | 16 | 3 | MP:0020180 | |
| MousePheno | abnormal lymphopoiesis | 1.94e-03 | 490 | 16 | 4 | MP:0002401 | |
| MousePheno | abnormal salivary gland physiology | 1.96e-03 | 58 | 16 | 2 | MP:0005310 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.99e-03 | 1269 | 16 | 6 | MP:0011111 | |
| MousePheno | open neural tube | 2.00e-03 | 226 | 16 | 3 | MP:0000929 | |
| MousePheno | increased B-1 B cell number | 2.02e-03 | 59 | 16 | 2 | MP:0004977 | |
| MousePheno | small maxilla | 2.02e-03 | 59 | 16 | 2 | MP:0004540 | |
| MousePheno | increased effector memory CD8-positive, alpha-beta T cell number | 2.02e-03 | 59 | 16 | 2 | MP:0010850 | |
| MousePheno | increased CD4-positive, alpha-beta memory T cell number | 2.02e-03 | 59 | 16 | 2 | MP:0010835 | |
| MousePheno | increased dendritic cell number | 2.09e-03 | 60 | 16 | 2 | MP:0008126 | |
| MousePheno | abnormal merocrine gland physiology | 2.09e-03 | 60 | 16 | 2 | MP:0013557 | |
| MousePheno | exencephaly | 2.10e-03 | 230 | 16 | 3 | MP:0000914 | |
| MousePheno | abnormal cell proliferation | 2.20e-03 | 1294 | 16 | 6 | MP:0000350 | |
| Domain | Nuc_rcpt_coact | 1.03e-05 | 6 | 16 | 2 | IPR009110 | |
| Domain | SH2 | 3.31e-03 | 101 | 16 | 2 | PF00017 | |
| Domain | SH2 | 3.91e-03 | 110 | 16 | 2 | SM00252 | |
| Domain | SH2 | 3.98e-03 | 111 | 16 | 2 | PS50001 | |
| Domain | SH2 | 4.05e-03 | 112 | 16 | 2 | IPR000980 | |
| Domain | - | 4.05e-03 | 112 | 16 | 2 | 3.30.505.10 | |
| Domain | - | 1.51e-02 | 222 | 16 | 2 | 1.25.10.10 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 7.92e-06 | 137 | 14 | 4 | M48232 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.11e-05 | 149 | 14 | 4 | M27888 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.28e-05 | 65 | 14 | 3 | M39682 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 5.11e-05 | 220 | 14 | 4 | M27794 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.00e-05 | 91 | 14 | 3 | M27101 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.02e-04 | 95 | 14 | 3 | M48268 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.39e-04 | 18 | 14 | 2 | M26942 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.61e-04 | 296 | 14 | 4 | M27869 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.98e-04 | 1432 | 14 | 7 | M509 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 2.09e-04 | 22 | 14 | 2 | MM15924 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.09e-04 | 22 | 14 | 2 | MM1370 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.45e-04 | 330 | 14 | 4 | M7847 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.50e-04 | 24 | 14 | 2 | M13404 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.94e-04 | 26 | 14 | 2 | MM14793 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 3.17e-04 | 27 | 14 | 2 | M26943 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.92e-04 | 30 | 14 | 2 | M207 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 4.19e-04 | 31 | 14 | 2 | M39522 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 4.47e-04 | 32 | 14 | 2 | M39521 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 5.05e-04 | 34 | 14 | 2 | M46422 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 7.71e-04 | 42 | 14 | 2 | M48237 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 7.71e-04 | 42 | 14 | 2 | M27272 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 7.71e-04 | 42 | 14 | 2 | M27172 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 8.46e-04 | 44 | 14 | 2 | M27295 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 1.01e-03 | 48 | 14 | 2 | M219 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.05e-03 | 49 | 14 | 2 | M41832 | |
| Pathway | PID_AR_TF_PATHWAY | 1.23e-03 | 53 | 14 | 2 | M151 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.32e-03 | 55 | 14 | 2 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.32e-03 | 55 | 14 | 2 | M27001 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.42e-03 | 233 | 14 | 3 | M27099 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.49e-03 | 237 | 14 | 3 | M27786 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.57e-03 | 60 | 14 | 2 | M41830 | |
| Pathway | PID_AR_PATHWAY | 1.62e-03 | 61 | 14 | 2 | M58 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.73e-03 | 63 | 14 | 2 | MM15613 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.78e-03 | 64 | 14 | 2 | M27046 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.89e-03 | 66 | 14 | 2 | M255 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 2.13e-03 | 70 | 14 | 2 | M938 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 2.19e-03 | 71 | 14 | 2 | MM15947 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.21e-03 | 272 | 14 | 3 | M29619 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 2.44e-03 | 75 | 14 | 2 | M5436 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 2.70e-03 | 79 | 14 | 2 | M11816 | |
| Pathway | PID_REG_GR_PATHWAY | 2.91e-03 | 82 | 14 | 2 | M115 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.91e-03 | 82 | 14 | 2 | M2 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 3.05e-03 | 84 | 14 | 2 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.57e-03 | 91 | 14 | 2 | M39700 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 3.96e-03 | 96 | 14 | 2 | M16121 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 3.96e-03 | 96 | 14 | 2 | M26973 | |
| Pathway | WP_B_CELL_RECEPTOR_SIGNALING | 4.04e-03 | 97 | 14 | 2 | M39323 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 4.04e-03 | 97 | 14 | 2 | M48262 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 4.29e-03 | 100 | 14 | 2 | MM15826 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 4.88e-03 | 360 | 14 | 3 | M27267 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 5.16e-03 | 110 | 14 | 2 | M48043 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.16e-03 | 110 | 14 | 2 | M48259 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.67e-10 | 457 | 16 | 7 | 32344865 | |
| Pubmed | 1.49e-09 | 268 | 16 | 6 | 33640491 | ||
| Pubmed | 2.87e-09 | 1429 | 16 | 9 | 35140242 | ||
| Pubmed | Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney. | 1.98e-07 | 2 | 16 | 2 | 30179902 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 19555349 | ||
| Pubmed | 3.08e-07 | 332 | 16 | 5 | 37433992 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.06e-07 | 351 | 16 | 5 | 38297188 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 15473004 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 33574497 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 20637214 | ||
| Pubmed | 6.13e-07 | 152 | 16 | 4 | 38360978 | ||
| Pubmed | EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation. | 1.19e-06 | 4 | 16 | 2 | 15987788 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 16613851 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 17704997 | ||
| Pubmed | A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies. | 1.19e-06 | 4 | 16 | 2 | 11583620 | |
| Pubmed | HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. | 1.19e-06 | 4 | 16 | 2 | 15638724 | |
| Pubmed | Sox9-Meis1 Inactivation Is Required for Adipogenesis, Advancing Pref-1+ to PDGFRα+ Cells. | 1.19e-06 | 4 | 16 | 2 | 30355480 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 15139295 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 17697320 | ||
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 14766010 | ||
| Pubmed | HIV-1 tat protein and cell proliferation and survival: a brief review. | 1.98e-06 | 5 | 16 | 2 | 16035254 | |
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 1.98e-06 | 5 | 16 | 2 | 24360964 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 1.98e-06 | 5 | 16 | 2 | 32808927 | |
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 1.98e-06 | 5 | 16 | 2 | 30760710 | |
| Pubmed | HIV-1 infection and regulation of Tat function in macrophages. | 1.98e-06 | 5 | 16 | 2 | 15183343 | |
| Pubmed | MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. | 1.98e-06 | 5 | 16 | 2 | 15657427 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 12810069 | ||
| Pubmed | CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. | 1.98e-06 | 5 | 16 | 2 | 17932106 | |
| Pubmed | The multiple functions of HIV-1 Tat: proliferation versus apoptosis. | 1.98e-06 | 5 | 16 | 2 | 16146763 | |
| Pubmed | 2.83e-06 | 61 | 16 | 3 | 20305087 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 17113272 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 15161102 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 9430642 | ||
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 9488450 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 2.97e-06 | 6 | 16 | 2 | 25184676 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 15731352 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 4.16e-06 | 7 | 16 | 2 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 4.16e-06 | 7 | 16 | 2 | 9192892 | |
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 30366904 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 23540691 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 28399410 | ||
| Pubmed | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. | 4.16e-06 | 7 | 16 | 2 | 24278015 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 4.16e-06 | 7 | 16 | 2 | 9590696 | |
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 5.55e-06 | 8 | 16 | 2 | 11971985 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 20541704 | ||
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 10490106 | ||
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 5.55e-06 | 8 | 16 | 2 | 28296634 | |
| Pubmed | 6.12e-06 | 1103 | 16 | 6 | 34189442 | ||
| Pubmed | HIV-1 chromatin, transcription, and the regulatory protein Tat. | 7.13e-06 | 9 | 16 | 2 | 24158816 | |
| Pubmed | 8.91e-06 | 10 | 16 | 2 | 17363140 | ||
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 22683124 | ||
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 11704662 | ||
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 18003620 | ||
| Pubmed | 1.26e-05 | 709 | 16 | 5 | 22988430 | ||
| Pubmed | 1.31e-05 | 12 | 16 | 2 | 11734557 | ||
| Pubmed | 1.54e-05 | 107 | 16 | 3 | 30995489 | ||
| Pubmed | 1.54e-05 | 13 | 16 | 2 | 11266503 | ||
| Pubmed | 1.80e-05 | 14 | 16 | 2 | 12482968 | ||
| Pubmed | 1.80e-05 | 14 | 16 | 2 | 28174279 | ||
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 23785148 | ||
| Pubmed | Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. | 2.69e-05 | 17 | 16 | 2 | 11547919 | |
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 19183483 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.76e-05 | 398 | 16 | 4 | 35016035 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.13e-05 | 411 | 16 | 4 | 35182466 | |
| Pubmed | Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1. | 3.38e-05 | 19 | 16 | 2 | 15142377 | |
| Pubmed | 3.75e-05 | 20 | 16 | 2 | 11877444 | ||
| Pubmed | 4.15e-05 | 21 | 16 | 2 | 19596656 | ||
| Pubmed | 4.30e-05 | 446 | 16 | 4 | 24255178 | ||
| Pubmed | 4.84e-05 | 157 | 16 | 3 | 30186101 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 4.99e-05 | 23 | 16 | 2 | 30962207 | |
| Pubmed | Hedgehog signalling controls sinoatrial node development and atrioventricular cushion formation. | 5.44e-05 | 24 | 16 | 2 | 34062094 | |
| Pubmed | 6.00e-05 | 486 | 16 | 4 | 20936779 | ||
| Pubmed | 6.92e-05 | 27 | 16 | 2 | 29374058 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 7.03e-05 | 178 | 16 | 3 | 27637333 | |
| Pubmed | 7.45e-05 | 28 | 16 | 2 | 24880616 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 8.76e-05 | 536 | 16 | 4 | 15840001 | |
| Pubmed | 8.89e-05 | 538 | 16 | 4 | 10512203 | ||
| Pubmed | 9.61e-05 | 549 | 16 | 4 | 38280479 | ||
| Pubmed | 1.10e-04 | 1116 | 16 | 5 | 31753913 | ||
| Pubmed | 1.10e-04 | 34 | 16 | 2 | 30894540 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.25e-04 | 588 | 16 | 4 | 38580884 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.32e-04 | 220 | 16 | 3 | 35785414 | |
| Pubmed | 1.46e-04 | 39 | 16 | 2 | 25859222 | ||
| Pubmed | 1.49e-04 | 615 | 16 | 4 | 31048545 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.53e-04 | 40 | 16 | 2 | 34585037 | |
| Pubmed | 1.71e-04 | 638 | 16 | 4 | 31182584 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.07e-04 | 670 | 16 | 4 | 22990118 | |
| Pubmed | 2.21e-04 | 48 | 16 | 2 | 22242598 | ||
| Pubmed | 2.87e-04 | 730 | 16 | 4 | 34857952 | ||
| Pubmed | 3.12e-04 | 57 | 16 | 2 | 18022353 | ||
| Pubmed | 3.12e-04 | 57 | 16 | 2 | 24952745 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 3.34e-04 | 59 | 16 | 2 | 28813667 | |
| Pubmed | Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. | 4.06e-04 | 65 | 16 | 2 | 23319000 | |
| Pubmed | 4.06e-04 | 65 | 16 | 2 | 22379092 | ||
| Pubmed | 4.06e-04 | 65 | 16 | 2 | 26655900 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.20e-04 | 1489 | 16 | 5 | 28611215 | |
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 4.31e-04 | 67 | 16 | 2 | 22711520 | |
| Interaction | NUP35 interactions | 3.99e-10 | 424 | 16 | 8 | int:NUP35 | |
| Interaction | ETV4 interactions | 1.72e-09 | 69 | 16 | 5 | int:ETV4 | |
| Interaction | TLE3 interactions | 7.37e-09 | 376 | 16 | 7 | int:TLE3 | |
| Interaction | ERG interactions | 1.25e-08 | 223 | 16 | 6 | int:ERG | |
| Interaction | AR interactions | 1.37e-08 | 992 | 16 | 9 | int:AR | |
| Interaction | SP7 interactions | 7.91e-08 | 304 | 16 | 6 | int:SP7 | |
| Interaction | EGR2 interactions | 1.68e-07 | 171 | 16 | 5 | int:EGR2 | |
| Interaction | TLX1 interactions | 1.88e-07 | 175 | 16 | 5 | int:TLX1 | |
| Interaction | MEX3A interactions | 3.14e-07 | 384 | 16 | 6 | int:MEX3A | |
| Interaction | IRF1 interactions | 4.69e-07 | 83 | 16 | 4 | int:IRF1 | |
| Interaction | CRX interactions | 1.19e-06 | 254 | 16 | 5 | int:CRX | |
| Interaction | PAX8 interactions | 1.51e-06 | 111 | 16 | 4 | int:PAX8 | |
| Interaction | TBR1 interactions | 1.62e-06 | 113 | 16 | 4 | int:TBR1 | |
| Interaction | TBXT interactions | 1.80e-06 | 116 | 16 | 4 | int:TBXT | |
| Interaction | TLX3 interactions | 2.33e-06 | 291 | 16 | 5 | int:TLX3 | |
| Interaction | PAX7 interactions | 2.35e-06 | 124 | 16 | 4 | int:PAX7 | |
| Interaction | PAX9 interactions | 2.83e-06 | 130 | 16 | 4 | int:PAX9 | |
| Interaction | SMG7 interactions | 3.65e-06 | 319 | 16 | 5 | int:SMG7 | |
| Interaction | NCOA6 interactions | 4.37e-06 | 145 | 16 | 4 | int:NCOA6 | |
| Interaction | PYGO2 interactions | 6.95e-06 | 48 | 16 | 3 | int:PYGO2 | |
| Interaction | LHX4 interactions | 7.48e-06 | 166 | 16 | 4 | int:LHX4 | |
| Interaction | ALG13 interactions | 1.10e-05 | 183 | 16 | 4 | int:ALG13 | |
| Interaction | TPRX2 interactions | 1.11e-05 | 56 | 16 | 3 | int:TPRX2 | |
| Interaction | MYOD1 interactions | 1.38e-05 | 194 | 16 | 4 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.41e-05 | 195 | 16 | 4 | int:KLF5 | |
| Interaction | FUS interactions | 1.60e-05 | 757 | 16 | 6 | int:FUS | |
| Interaction | CNOT3 interactions | 1.79e-05 | 207 | 16 | 4 | int:CNOT3 | |
| Interaction | GCM1 interactions | 1.99e-05 | 68 | 16 | 3 | int:GCM1 | |
| Interaction | EYA4 interactions | 3.35e-05 | 243 | 16 | 4 | int:EYA4 | |
| Interaction | SOX7 interactions | 3.50e-05 | 82 | 16 | 3 | int:SOX7 | |
| Interaction | PGR interactions | 3.76e-05 | 84 | 16 | 3 | int:PGR | |
| Interaction | IRF4 interactions | 3.90e-05 | 85 | 16 | 3 | int:IRF4 | |
| Interaction | HNF4A interactions | 5.43e-05 | 275 | 16 | 4 | int:HNF4A | |
| Interaction | SOX17 interactions | 5.44e-05 | 95 | 16 | 3 | int:SOX17 | |
| Interaction | ARID1A interactions | 5.50e-05 | 276 | 16 | 4 | int:ARID1A | |
| Interaction | SOX2 interactions | 5.57e-05 | 1422 | 16 | 7 | int:SOX2 | |
| Interaction | AIRE interactions | 5.78e-05 | 97 | 16 | 3 | int:AIRE | |
| Interaction | GLI3 interactions | 5.96e-05 | 98 | 16 | 3 | int:GLI3 | |
| Interaction | SS18L1 interactions | 5.96e-05 | 98 | 16 | 3 | int:SS18L1 | |
| Interaction | RBBP5 interactions | 6.40e-05 | 287 | 16 | 4 | int:RBBP5 | |
| Interaction | KLF15 interactions | 6.67e-05 | 290 | 16 | 4 | int:KLF15 | |
| Interaction | CREBBP interactions | 7.59e-05 | 599 | 16 | 5 | int:CREBBP | |
| Interaction | THRA interactions | 8.64e-05 | 111 | 16 | 3 | int:THRA | |
| Interaction | FOS interactions | 8.85e-05 | 312 | 16 | 4 | int:FOS | |
| Interaction | H3-3B interactions | 9.36e-05 | 114 | 16 | 3 | int:H3-3B | |
| Interaction | CARM1 interactions | 1.04e-04 | 325 | 16 | 4 | int:CARM1 | |
| Interaction | DDIT3 interactions | 1.09e-04 | 120 | 16 | 3 | int:DDIT3 | |
| Interaction | ETS1 interactions | 1.12e-04 | 121 | 16 | 3 | int:ETS1 | |
| Interaction | HOXB4 interactions | 1.23e-04 | 21 | 16 | 2 | int:HOXB4 | |
| Interaction | HOXA11 interactions | 1.23e-04 | 21 | 16 | 2 | int:HOXA11 | |
| Interaction | SMARCB1 interactions | 1.60e-04 | 364 | 16 | 4 | int:SMARCB1 | |
| Interaction | PHF10 interactions | 1.68e-04 | 139 | 16 | 3 | int:PHF10 | |
| Interaction | NCOA2 interactions | 1.76e-04 | 141 | 16 | 3 | int:NCOA2 | |
| Interaction | TLX2 interactions | 1.79e-04 | 142 | 16 | 3 | int:TLX2 | |
| Interaction | HOXB7 interactions | 1.90e-04 | 26 | 16 | 2 | int:HOXB7 | |
| Interaction | PDX1 interactions | 1.90e-04 | 26 | 16 | 2 | int:PDX1 | |
| Interaction | NCOA1 interactions | 1.95e-04 | 146 | 16 | 3 | int:NCOA1 | |
| Interaction | SMARCC1 interactions | 1.97e-04 | 384 | 16 | 4 | int:SMARCC1 | |
| Interaction | SNW1 interactions | 2.14e-04 | 747 | 16 | 5 | int:SNW1 | |
| Interaction | CPVL interactions | 2.37e-04 | 156 | 16 | 3 | int:CPVL | |
| Interaction | HOXD4 interactions | 2.54e-04 | 30 | 16 | 2 | int:HOXD4 | |
| Interaction | HOXD12 interactions | 2.54e-04 | 30 | 16 | 2 | int:HOXD12 | |
| Interaction | CEBPA interactions | 2.57e-04 | 1245 | 16 | 6 | int:CEBPA | |
| Interaction | BRCA1 interactions | 2.61e-04 | 1249 | 16 | 6 | int:BRCA1 | |
| Interaction | MDC1 interactions | 2.63e-04 | 414 | 16 | 4 | int:MDC1 | |
| Interaction | SNIP1 interactions | 2.70e-04 | 417 | 16 | 4 | int:SNIP1 | |
| Interaction | PRLR interactions | 2.71e-04 | 31 | 16 | 2 | int:PRLR | |
| Interaction | CRTC1 interactions | 2.71e-04 | 31 | 16 | 2 | int:CRTC1 | |
| Interaction | CEP85 interactions | 2.99e-04 | 169 | 16 | 3 | int:CEP85 | |
| Interaction | HOXA9 interactions | 3.27e-04 | 34 | 16 | 2 | int:HOXA9 | |
| Interaction | ARID1B interactions | 3.43e-04 | 177 | 16 | 3 | int:ARID1B | |
| Interaction | SMAD3 interactions | 3.52e-04 | 447 | 16 | 4 | int:SMAD3 | |
| Interaction | NKX2-1 interactions | 3.60e-04 | 180 | 16 | 3 | int:NKX2-1 | |
| Interaction | KAT2A interactions | 3.60e-04 | 180 | 16 | 3 | int:KAT2A | |
| Interaction | E2F5 interactions | 3.66e-04 | 36 | 16 | 2 | int:E2F5 | |
| Interaction | LHX2 interactions | 3.78e-04 | 183 | 16 | 3 | int:LHX2 | |
| Interaction | KLF1 interactions | 3.87e-04 | 37 | 16 | 2 | int:KLF1 | |
| Interaction | LHX3 interactions | 3.90e-04 | 185 | 16 | 3 | int:LHX3 | |
| Interaction | NFIA interactions | 4.09e-04 | 188 | 16 | 3 | int:NFIA | |
| Interaction | HNF1B interactions | 4.22e-04 | 190 | 16 | 3 | int:HNF1B | |
| Interaction | RORA interactions | 4.30e-04 | 39 | 16 | 2 | int:RORA | |
| Interaction | HOXB1 interactions | 4.76e-04 | 41 | 16 | 2 | int:HOXB1 | |
| Interaction | BCAT2 interactions | 4.76e-04 | 41 | 16 | 2 | int:BCAT2 | |
| Interaction | GATA2 interactions | 4.83e-04 | 199 | 16 | 3 | int:GATA2 | |
| Interaction | AP2A2 interactions | 4.83e-04 | 199 | 16 | 3 | int:AP2A2 | |
| Interaction | NFATC2 interactions | 4.90e-04 | 200 | 16 | 3 | int:NFATC2 | |
| Interaction | FEV interactions | 5.12e-04 | 203 | 16 | 3 | int:FEV | |
| Interaction | EWSR1 interactions | 5.24e-04 | 906 | 16 | 5 | int:EWSR1 | |
| Interaction | GMEB1 interactions | 5.74e-04 | 45 | 16 | 2 | int:GMEB1 | |
| Interaction | ZC3H7A interactions | 6.05e-04 | 215 | 16 | 3 | int:ZC3H7A | |
| Interaction | BCL9L interactions | 6.53e-04 | 48 | 16 | 2 | int:BCL9L | |
| Interaction | RARA interactions | 6.73e-04 | 223 | 16 | 3 | int:RARA | |
| Interaction | TP53BP1 interactions | 6.84e-04 | 533 | 16 | 4 | int:TP53BP1 | |
| Interaction | FOXC1 interactions | 7.18e-04 | 228 | 16 | 3 | int:FOXC1 | |
| Interaction | NR3C1 interactions | 7.29e-04 | 974 | 16 | 5 | int:NR3C1 | |
| Interaction | EID1 interactions | 7.37e-04 | 51 | 16 | 2 | int:EID1 | |
| Interaction | CNOT9 interactions | 7.45e-04 | 231 | 16 | 3 | int:CNOT9 | |
| Interaction | MEIS1 interactions | 7.66e-04 | 52 | 16 | 2 | int:MEIS1 | |
| Interaction | ANAPC2 interactions | 7.74e-04 | 234 | 16 | 3 | int:ANAPC2 | |
| Interaction | TERF2IP interactions | 7.79e-04 | 552 | 16 | 4 | int:TERF2IP | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.55e-05 | 17 | 11 | 2 | 486 | |
| GeneFamily | SH2 domain containing | 1.64e-03 | 101 | 11 | 2 | 741 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 2.13e-06 | 157 | 16 | 4 | M7733 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 1.92e-05 | 11 | 16 | 2 | MM17503 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 2.02e-04 | 192 | 16 | 3 | M8272 | |
| Coexpression | GSE3982_MAC_VS_BCELL_DN | 2.18e-04 | 197 | 16 | 3 | M5495 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 2.24e-04 | 199 | 16 | 3 | M9255 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP | 2.24e-04 | 199 | 16 | 3 | M3639 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.24e-04 | 199 | 16 | 3 | M6987 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP | 2.28e-04 | 200 | 16 | 3 | M5134 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 2.28e-04 | 200 | 16 | 3 | M5991 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP | 2.28e-04 | 200 | 16 | 3 | M3648 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 2.28e-04 | 200 | 16 | 3 | M5901 | |
| Coexpression | GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN | 2.28e-04 | 200 | 16 | 3 | M8506 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 1.43e-04 | 372 | 16 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 1.63e-04 | 385 | 16 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 1.71e-04 | 26 | 16 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.23e-04 | 418 | 16 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 2.40e-04 | 806 | 16 | 5 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 2.53e-04 | 432 | 16 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_200 | 2.90e-04 | 176 | 16 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 3.20e-04 | 858 | 16 | 5 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 5.40e-04 | 46 | 16 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.88e-04 | 48 | 16 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 6.38e-04 | 50 | 16 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_500 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 145 | 16 | 3 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.18e-05 | 193 | 16 | 3 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.18e-05 | 193 | 16 | 3 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.24e-05 | 194 | 16 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.31e-05 | 195 | 16 | 3 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 199 | 16 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-03 | 139 | 16 | 2 | aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c | |
| ToppCell | 356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-03 | 139 | 16 | 2 | b9c2dfab119ac0efdf931bb2910e82bccdb4e48d | |
| ToppCell | Control-NK|World / Disease group and Cell class | 1.17e-03 | 143 | 16 | 2 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.19e-03 | 144 | 16 | 2 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-03 | 158 | 16 | 2 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-03 | 159 | 16 | 2 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-03 | 159 | 16 | 2 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-03 | 159 | 16 | 2 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.44e-03 | 159 | 16 | 2 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-03 | 159 | 16 | 2 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.50e-03 | 162 | 16 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-03 | 162 | 16 | 2 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-03 | 163 | 16 | 2 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-03 | 163 | 16 | 2 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-03 | 163 | 16 | 2 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.57e-03 | 166 | 16 | 2 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-03 | 167 | 16 | 2 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 167 | 16 | 2 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 167 | 16 | 2 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-03 | 167 | 16 | 2 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 167 | 16 | 2 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-03 | 168 | 16 | 2 | d19a115365c5415e51c039718d7669de788fcf33 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 1.61e-03 | 168 | 16 | 2 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.61e-03 | 168 | 16 | 2 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-03 | 168 | 16 | 2 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-03 | 169 | 16 | 2 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-03 | 169 | 16 | 2 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-03 | 169 | 16 | 2 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-03 | 171 | 16 | 2 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-03 | 174 | 16 | 2 | c0204a0d0a979a489e8d30dc5396e99da14c119c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-03 | 174 | 16 | 2 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-03 | 175 | 16 | 2 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 1.74e-03 | 175 | 16 | 2 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-03 | 176 | 16 | 2 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-03 | 176 | 16 | 2 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-03 | 177 | 16 | 2 | 4943d040eee0f9dceaddc7498171281d170e271f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-03 | 177 | 16 | 2 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-03 | 177 | 16 | 2 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-03 | 177 | 16 | 2 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-03 | 177 | 16 | 2 | 3f2272b577c862dba8ccfb41184054bbd0ace6f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-03 | 178 | 16 | 2 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 178 | 16 | 2 | 5ac5257d88fa0dc67714881d6f005f6cea925710 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.82e-03 | 179 | 16 | 2 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-03 | 179 | 16 | 2 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-03 | 180 | 16 | 2 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-03 | 180 | 16 | 2 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | (0)_Normal/No_Treatment|World / Stress and Cell class | 1.86e-03 | 181 | 16 | 2 | 4077282c45a37403f47e8d1b9ac102e6b1ba2cf9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-03 | 182 | 16 | 2 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-03 | 182 | 16 | 2 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-03 | 183 | 16 | 2 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-03 | 183 | 16 | 2 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-03 | 184 | 16 | 2 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-03 | 184 | 16 | 2 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.94e-03 | 185 | 16 | 2 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 185 | 16 | 2 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 185 | 16 | 2 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 185 | 16 | 2 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-03 | 185 | 16 | 2 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.94e-03 | 185 | 16 | 2 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.94e-03 | 185 | 16 | 2 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 185 | 16 | 2 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.96e-03 | 186 | 16 | 2 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.96e-03 | 186 | 16 | 2 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-03 | 187 | 16 | 2 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.98e-03 | 187 | 16 | 2 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-03 | 187 | 16 | 2 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-03 | 187 | 16 | 2 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-03 | 188 | 16 | 2 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-03 | 188 | 16 | 2 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-03 | 188 | 16 | 2 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 2.01e-03 | 188 | 16 | 2 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-03 | 189 | 16 | 2 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.03e-03 | 189 | 16 | 2 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.03e-03 | 189 | 16 | 2 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-03 | 189 | 16 | 2 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-03 | 189 | 16 | 2 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-03 | 189 | 16 | 2 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 2.03e-03 | 189 | 16 | 2 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-03 | 189 | 16 | 2 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-03 | 189 | 16 | 2 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-03 | 189 | 16 | 2 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-03 | 189 | 16 | 2 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.05e-03 | 190 | 16 | 2 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 190 | 16 | 2 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 190 | 16 | 2 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 190 | 16 | 2 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 190 | 16 | 2 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 190 | 16 | 2 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.05e-03 | 190 | 16 | 2 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-03 | 190 | 16 | 2 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-03 | 190 | 16 | 2 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.05e-03 | 190 | 16 | 2 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 190 | 16 | 2 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-03 | 191 | 16 | 2 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| Computational | Genes in the cancer module 397. | 3.66e-04 | 121 | 13 | 3 | MODULE_397 | |
| Drug | MF101 extract | 4.62e-06 | 5 | 16 | 2 | ctd:C517398 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.97e-06 | 169 | 16 | 4 | 6064_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.33e-06 | 172 | 16 | 4 | 2794_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.84e-06 | 176 | 16 | 4 | 7499_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.12e-06 | 197 | 16 | 4 | 5292_DN | |
| Drug | monomethyl phthalate | 3.02e-05 | 957 | 16 | 6 | ctd:C517284 | |
| Drug | 1,1,1-trichloroethane | 1.65e-04 | 156 | 16 | 3 | CID000006278 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.88e-04 | 163 | 16 | 3 | 7453_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.95e-04 | 165 | 16 | 3 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.99e-04 | 166 | 16 | 3 | 2268_DN | |
| Drug | dicyclohexyl phthalate | 2.05e-04 | 836 | 16 | 5 | ctd:C036042 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.06e-04 | 168 | 16 | 3 | 3395_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.10e-04 | 169 | 16 | 3 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-04 | 170 | 16 | 3 | 3791_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.13e-04 | 170 | 16 | 3 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.17e-04 | 171 | 16 | 3 | 1234_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.17e-04 | 171 | 16 | 3 | 4954_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 6439_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 2330_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 1637_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.21e-04 | 172 | 16 | 3 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.21e-04 | 172 | 16 | 3 | 6993_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.24e-04 | 173 | 16 | 3 | 5987_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.24e-04 | 173 | 16 | 3 | 4665_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.24e-04 | 173 | 16 | 3 | 5336_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.24e-04 | 173 | 16 | 3 | 2881_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.24e-04 | 173 | 16 | 3 | 3243_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.28e-04 | 174 | 16 | 3 | 3462_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.28e-04 | 174 | 16 | 3 | 1659_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.28e-04 | 174 | 16 | 3 | 7530_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.28e-04 | 174 | 16 | 3 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.28e-04 | 174 | 16 | 3 | 5065_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.32e-04 | 175 | 16 | 3 | 1058_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.32e-04 | 175 | 16 | 3 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.32e-04 | 175 | 16 | 3 | 6316_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.32e-04 | 175 | 16 | 3 | 7236_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.32e-04 | 175 | 16 | 3 | 1014_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.36e-04 | 176 | 16 | 3 | 6546_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.36e-04 | 176 | 16 | 3 | 1535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.36e-04 | 176 | 16 | 3 | 3312_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.36e-04 | 176 | 16 | 3 | 1212_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.36e-04 | 176 | 16 | 3 | 6784_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.36e-04 | 176 | 16 | 3 | 981_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.40e-04 | 177 | 16 | 3 | 873_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 1645_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 6340_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 3227_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 5308_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.40e-04 | 177 | 16 | 3 | 3177_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.44e-04 | 178 | 16 | 3 | 4184_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.44e-04 | 178 | 16 | 3 | 7245_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.44e-04 | 178 | 16 | 3 | 1112_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.44e-04 | 178 | 16 | 3 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.44e-04 | 178 | 16 | 3 | 5086_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.48e-04 | 179 | 16 | 3 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.48e-04 | 179 | 16 | 3 | 2105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.48e-04 | 179 | 16 | 3 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.48e-04 | 179 | 16 | 3 | 4483_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.52e-04 | 180 | 16 | 3 | 6454_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.52e-04 | 180 | 16 | 3 | 3688_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.52e-04 | 180 | 16 | 3 | 6886_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.52e-04 | 180 | 16 | 3 | 4821_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.56e-04 | 181 | 16 | 3 | 7077_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.56e-04 | 181 | 16 | 3 | 6951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.56e-04 | 181 | 16 | 3 | 7005_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.61e-04 | 182 | 16 | 3 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.61e-04 | 182 | 16 | 3 | 1951_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 2.61e-04 | 182 | 16 | 3 | 6896_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.65e-04 | 183 | 16 | 3 | 4770_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 184 | 16 | 3 | 2321_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.69e-04 | 184 | 16 | 3 | 6939_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.69e-04 | 184 | 16 | 3 | 4349_DN | |
| Drug | Cyproterone Acetate | 2.72e-04 | 35 | 16 | 2 | ctd:D017373 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.73e-04 | 185 | 16 | 3 | 5882_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.82e-04 | 187 | 16 | 3 | 6671_DN | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | 2.87e-04 | 188 | 16 | 3 | 2161_DN | |
| Drug | fulvestrant | 3.00e-04 | 484 | 16 | 4 | ctd:C070081 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.00e-04 | 191 | 16 | 3 | 7503_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 3811_UP | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 3.10e-04 | 193 | 16 | 3 | 6751_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.14e-04 | 194 | 16 | 3 | 4341_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; HL60; HT_HG-U133A | 3.14e-04 | 194 | 16 | 3 | 1293_UP | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 4646_DN | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 6670_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 5005_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 2914_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 1628_DN | |
| Drug | ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 3.24e-04 | 196 | 16 | 3 | 918_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2128_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; HL60; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 2915_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 3444_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 5829_DN | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6358_UP | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7193_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 4991_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6265_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6300_DN | |
| Disease | Adenoid Cystic Carcinoma | 2.05e-05 | 100 | 16 | 3 | C0010606 | |
| Disease | neutrophil count | 5.57e-05 | 1382 | 16 | 6 | EFO_0004833 | |
| Disease | Sezary Syndrome | 9.60e-05 | 27 | 16 | 2 | C0036920 | |
| Disease | Squamous cell carcinoma of lung | 1.35e-04 | 32 | 16 | 2 | C0149782 | |
| Disease | HVA measurement, 5-HIAA measurement | 2.02e-04 | 39 | 16 | 2 | EFO_0005131, EFO_0005132 | |
| Disease | Carcinoma, Transitional Cell | 2.23e-04 | 41 | 16 | 2 | C0007138 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 2.46e-04 | 43 | 16 | 2 | DOID:9074 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.80e-04 | 616 | 16 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.80e-04 | 616 | 16 | 4 | C0376358 | |
| Disease | urate measurement, bone density | 2.86e-04 | 619 | 16 | 4 | EFO_0003923, EFO_0004531 | |
| Disease | pre-eclampsia (is_marker_for) | 4.48e-04 | 58 | 16 | 2 | DOID:10591 (is_marker_for) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 9.36e-04 | 84 | 16 | 2 | DOID:9119 (is_implicated_in) | |
| Disease | bilirubin measurement | 1.62e-03 | 442 | 16 | 3 | EFO_0004570 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.67e-03 | 447 | 16 | 3 | EFO_0000694, MONDO_0100096 | |
| Disease | Squamous cell carcinoma | 2.02e-03 | 124 | 16 | 2 | C0007137 | |
| Disease | verbal-numerical reasoning measurement | 2.25e-03 | 131 | 16 | 2 | EFO_0008394 | |
| Disease | viral load | 2.43e-03 | 136 | 16 | 2 | EFO_0010125 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.53e-03 | 139 | 16 | 2 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 2.57e-03 | 140 | 16 | 2 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.60e-03 | 141 | 16 | 2 | C0005684 | |
| Disease | stomach cancer (is_marker_for) | 2.64e-03 | 142 | 16 | 2 | DOID:10534 (is_marker_for) | |
| Disease | Breast Carcinoma | 2.83e-03 | 538 | 16 | 3 | C0678222 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.86e-03 | 148 | 16 | 2 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPGGYPPAMQQQQRM | 2236 | Q92793 | |
| NFSFPSLPTMGQMPG | 601 | O60563 | |
| QGAGPMQAMAPQGAP | 891 | Q5TC82 | |
| TPYNPDGQPMGGFVM | 346 | O00470 | |
| RPPGYPNMNQGGMMG | 911 | O14497 | |
| PNMNQGGMMGTGPPY | 916 | O14497 | |
| INPQGPPYSMGGTMA | 941 | O14497 | |
| ARQPGFMEPQTGPMG | 1346 | P10070 | |
| LGQNFSPPSGQMMPG | 171 | Q9BRQ0 | |
| MGGPSNFAQNTMPYP | 646 | Q86UU0 | |
| INPNYMGVGPFGPPM | 911 | Q92835 | |
| MNMGGPQYSQQQAPP | 1016 | Q15596 | |
| PNMGPNPGMDGDCVY | 191 | O00295 | |
| QNMPMGPGGMNQSGP | 81 | Q15532 | |
| GGGPPAPHMQNQMNG | 111 | Q15532 | |
| MSQGQPMGNYGPRPN | 181 | Q15532 | |
| TQMPEGGQGAPPMYQ | 946 | P78527 | |
| MVAMQNYHGNPAPPG | 591 | P52735 | |
| MQPGVNGPMGTNFQV | 551 | Q8NDV7 | |
| SGGPFQPGMNMQAFP | 1771 | Q9BYP7 |